1.
Acta Pharmaceutica Sinica B
;
(6): 1592-1606, 2021.
Article
in English
| WPRIM
| ID: wpr-888822
ABSTRACT
HYD-PEP06, an endostatin-modified polypeptide, has been shown to produce effective anti-colorectal carcinoma effects through inhibiting epithelial-mesenchymal transition (EMT). However, whether HYD-PEP06 has similar suppressive effect on hepatocellular carcinoma (HCC) remained unknown. In this study, HYD-PEP06 inhibited metastasis and EMT but not proliferation